Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Abbrederis K, Kremer M, Schuhmacher C (2007) Ischämische Anastomosenperforation im Bereich einer Ileotransversostomie unter Therapie mit Bevacizumab. Chirurg 78
2. Cannistra SA, Matulonis U, Penson R et al. (2006) Bevacizumab in patients with platinum-resistant ovarian cancer. J Clin Oncol 24 [Suppl 18]: 5006 (Abstr)
3. Ellis LM, Curley SA, Grothey A (2005) Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab. J Clin Oncol 23: 4853
4. Ferrara N (2002) Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications. Semin Oncol 6 [Suppl 16] 29: 10
5. Ferrara N, Hillan KJ, Gerber HP, Novotny W (2004) Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 3: 391
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Biologisch zielgerichtete medikamentöse Therapie;Praxis der Viszeralchirurgie Onkologische Chirurgie;2010
2. Entwicklungen der modernen Onkologie;Der Anaesthesist;2009-05-20